Home
/
Astrana Health, Inc.
/
Financials
/
Quarterly
Astrana Health, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Astrana Health, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Mar 31, 2019
$95.76M
May 10, 2019
Q3
2018
Sep 30, 2018
$167.28M
Nov 14, 2018
Q2
2018
Jun 30, 2018
$123.00M
Aug 14, 2018
Q1
2019
Mar 31, 2018
$123.92M
May 10, 2019
Q2
2018
Sep 30, 2017
$40.48M
Nov 14, 2017
Q3
2018
Sep 30, 2017
$97.13M
Nov 14, 2018
Q1
2018
Jun 30, 2017
$41.58M
Aug 14, 2017
Q2
2018
Jun 30, 2017
$81.31M
Aug 14, 2018
Q3
2017
Dec 31, 2016
$15.67M
Feb 14, 2017
Q2
2018
Sep 30, 2016
$14.62M
Nov 14, 2017
Q1
2018
Jun 30, 2016
$12.37M
Aug 14, 2017
Q3
2017
Dec 31, 2015
$10.66M
Feb 14, 2017
Q2
2017
Sep 30, 2015
$11.37M
Nov 14, 2016
Q1
2017
Jun 30, 2015
$10.20M
Aug 15, 2016
Q3
2016
Dec 31, 2014
$7.64M
Feb 16, 2016
Q2
2016
Sep 30, 2014
$11.67M
Nov 17, 2015
Q1
2016
Jun 30, 2014
$4.09M
Aug 28, 2015
Q3
2015
Dec 31, 2013
$2.83M
Feb 23, 2015
Q3
2013
Oct 31, 2013
$2.61M
Dec 20, 2013
Q2
2015
Sep 30, 2013
$2.52M
Nov 14, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$956.05M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$654.81M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$620.39M
May 9, 2025
Q3
2025
Sep 30, 2024
$478.71M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$486.27M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$404.36M
May 9, 2025
Q3
2024
Sep 30, 2023
$348.17M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$348.21M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$337.24M
May 9, 2024
Q3
2023
Sep 30, 2022
$317.00M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$269.70M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$263.26M
Aug 9, 2023
Q3
2022
Sep 30, 2021
$227.12M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$175.64M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$176.06M
May 10, 2022
Q3
2021
Sep 30, 2020
$180.12M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$165.17M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$165.11M
May 7, 2021
Q3
2020
Sep 30, 2019
$156.06M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$130.05M
Aug 10, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$124.17M
May 15, 2018
Q1
2018
Mar 31, 2017
$85.34M
May 15, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$373.0K
Nov 10, 2025
Q2
2025
Jun 30, 2025
$9.42M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$6.69M
May 9, 2025
Q3
2025
Sep 30, 2024
$16.09M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$19.17M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$14.84M
May 9, 2025
Q3
2024
Sep 30, 2023
$22.06M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$13.17M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$13.13M
May 9, 2024
Q3
2023
Sep 30, 2022
$23.19M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$11.95M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$13.76M
Aug 9, 2023
Q3
2022
Sep 30, 2021
$34.28M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$12.66M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$13.15M
May 10, 2022
Q3
2021
Sep 30, 2020
$16.71M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$7.04M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$4.05M
May 7, 2021
Q3
2020
Sep 30, 2019
$3.70M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$3.55M
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$19.21M
Nov 10, 2025
Q2
2025
Jun 30, 2025
$20.34M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$20.58M
May 9, 2025
Q3
2025
Sep 30, 2024
$28.43M
Nov 10, 2025
Q2
2025
Jun 30, 2024
$30.07M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$30.14M
May 9, 2025
Q3
2024
Sep 30, 2023
$39.08M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$27.03M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$22.37M
May 9, 2024
Q3
2023
Sep 30, 2022
$50.09M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$15.38M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$26.21M
Aug 9, 2023
Q3
2022
Sep 30, 2021
$53.16M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$20.99M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$21.78M
May 10, 2022
Q3
2021
Sep 30, 2020
$37.36M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$12.91M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$4.37M
May 7, 2021
Q3
2020
Sep 30, 2019
$10.07M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$14.73M
Aug 10, 2020